SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma recalls 31,762 bottles of anti-depressant drug in US

13 Oct 2016 Evaluate

Sun Pharmaceutical Industries is recalling 31,762 bottles of bupropion hydrochloride extended- release tablets used for treatment of major depressive disorder in the United States due to failed dissolution specifications. The recall has been initiated for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg.

This was a ‘Class III’ recall, initiated voluntarily by the company. Such a recall is initiated where use of or exposure to a violative product is not likely to cause adverse health consequences. The tablets were made by the company at its Halol (Gujarat) unit, already under an FDA scanner.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1847.30 12.90 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×